THE FIRST FDA-APPROVED FRONT-LINE THERAPY IN MORE THAN 4 DECADES1 INDICATION IMPORTANT SAFETY INFORMATION FOR LARTRUVO Warnings and Precautions Infusion-Related Reactions Embryo-Fetal Toxicity α α Most Common Adverse Reactions/Lab Abnormalities Please see Brief Summary of Prescribing Information for LARTRUVO on adjacent pages of this advertisement.
20109GA
To see the actual publication please follow the link above